CN105362865A - Tussilago farfara combination medicine for treating bronchitis - Google Patents
Tussilago farfara combination medicine for treating bronchitis Download PDFInfo
- Publication number
- CN105362865A CN105362865A CN201510865957.7A CN201510865957A CN105362865A CN 105362865 A CN105362865 A CN 105362865A CN 201510865957 A CN201510865957 A CN 201510865957A CN 105362865 A CN105362865 A CN 105362865A
- Authority
- CN
- China
- Prior art keywords
- gram
- combination medicine
- tussilago farfara
- radix
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/904—Stemonaceae (Stemona family), e.g. croomia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to tussilago farfara combination medicine for treating bronchitis. The tussilago farfara combination medicine is characterized by comprising, by weight, 40-50g of tussilago farfara, 40-50g of cortex mori radicis, 40-50g of radix platycodi, 40-50g of radix stemonae, 40-50g of radix glycyrrhizae, 6-25g of periostracum cicada and 10-25g of bombyx batryticatus. The tussilago farfara combination medicine is prepared by smashing the medicinal raw materials and packaging. The tussilago farfara combination medicine is easy in raw material obtaining, low in cost, evident in curative effect, and the like.
Description
Technical field
The present invention relates to a kind of Chinese patent medicine, particularly a kind of instant particles as Chinese medicine.
Background technology
Bronchial asthma is the chronic airway inflammation disease participated in by various kinds of cell and cellular component, this chronic inflammatory disease is relevant to airway hyperreactivity, the reversible airflow limitation that usual appearance is extensive and changeable, cause the symptoms such as the panting of recurrent exerbation, tachypnea, uncomfortable in chest and (or) cough, how in night and (or) outbreak in early morning, aggravation, most of patients can spontaneous remission or alleviate through treatment.
Summary of the invention
The object of the invention is to: propose one and treat bronchitic Flos Farfarae composition of medicine.
The bronchitic Flos Farfarae composition of medicine for the treatment of of the present invention, is characterized in that: by weight, by Flos Farfarae 40-50 gram, and Cortex Mori 40-50 gram, Radix Platycodonis 40-50 gram, Radix Stemonae 40-50 gram, Radix Glycyrrhizae 40-50 gram, Periostracum Cicadae 6-25 gram, Bombyx Batryticatus 10-25 gram; Pulverize, packaging, obtains product.
Function cures mainly: lung heat clearing is regulated the flow of vital energy, preventing phlegm from forming and stopping coughing.For acute tracheitis, bronochitic.
Packaging: can be every pouch 30g or every bag of 500 grams of-1000 grams of specifications.
Usage: pour medicated powder 30g into electric cup, 30-40 minute after the 200ml that adds water boils, gets liquid and uses; A little Mel drink-service can be added.1 day 3-5 time.It within 15 days, is 1 course for the treatment of.
The bronchitic Flos Farfarae composition of medicine for the treatment of of the present invention, is characterized in that: by weight, by Flos Farfarae 40-50 gram, and Cortex Mori 40-50 gram, Radix Platycodonis 40-50 gram, Radix Stemonae 40-50 gram, Radix Glycyrrhizae 40-50 gram, Periostracum Cicadae 6-25 gram, Bombyx Batryticatus 10-25 gram; Adopt the method for prior art, make Tablet and Capsula product.
The present invention has the following advantages and effect: the advantages such as it has raw material and is easy to get, and cost is low, and therapeutic effect is remarkable.
Detailed description of the invention
Below in conjunction with test and clinical trial situation, technical scheme of the present invention is described in further detail.
Embodiment 1
The bronchitic Flos Farfarae composition of medicine for the treatment of of the present invention, is characterized in that: by weight, by Flos Farfarae 40-50 gram, and Cortex Mori 40-50 gram, Radix Platycodonis 40-50 gram, Radix Stemonae 40-50 gram, Radix Glycyrrhizae 40-50 gram, Periostracum Cicadae 6-25 gram, Bombyx Batryticatus 10-25 gram; Pulverize, packaging, obtains product.
Function cures mainly: lung heat clearing is regulated the flow of vital energy, preventing phlegm from forming and stopping coughing.For acute tracheitis, bronochitic.
Packaging: can be every pouch 30g or every bag of 500 grams of-1000 grams of specifications.
Usage: pour medicated powder 30g into electric cup, 30-40 minute after the 200ml that adds water boils, gets liquid and uses; A little Mel drink-service can be added.1 day 3-5 time.It within 15 days, is 1 course for the treatment of.
Embodiment 2
The bronchitic Flos Farfarae composition of medicine for the treatment of of the present invention, is characterized in that: by weight, by Flos Farfarae 50 grams, and Cortex Mori 50 grams, Radix Platycodonis 50 grams, the Radix Stemonae 40 grams, 50 grams, Radix Glycyrrhizae, Periostracum Cicadae 6 grams, Bombyx Batryticatus 25 grams; Pulverize, packaging, obtains product.
Function cures mainly: lung heat clearing is regulated the flow of vital energy, preventing phlegm from forming and stopping coughing.For acute tracheitis, bronochitic.
Packaging: can be every pouch 30g or every bag of 500 grams of-1000 grams of specifications.
Usage: pour medicated powder 30g into electric cup, 30-40 minute after the 200ml that adds water boils, gets liquid and uses; A little Mel drink-service can be added.1 day 3-5 time.It within 15 days, is 1 course for the treatment of.
By this side treatment 150 example, cure 115 examples, take a turn for the better 35 examples, to cold and heat not notably effective percentage 100%.
Model case:
Lee, man, 56 years old, sooner or later cough was outstanding heavy, and copious thick sticky phlegm glues, and folder white foam, though with western medicines in treatment, still paroxysmal cough, general malaise, body temperature 36.8 DEG C, x-ray is taken the photograph sheet and is shown twice lung increased bronchovascular shadows; Blood routine examination, numeration of leukocyte is in normal range, and neutrophilic granulocyte is higher.Treat with this side of the present invention; Treat 3 courses for the treatment of, follow up a case by regular visits to 2 years, have no recurrence.
Wu, man, 32 years old.Because of fever with aversion to cold after suffering from cold, body temperature 39.2 DEG C, leukocyte 11.8 × 109/L.Cough rough, Chest X-rays: two increased bronchovascular shadows.The rule for the treatment of should lung clearing heat, eliminating phlegm, relieving cough.Treat with this side of the present invention; Take medicine, after 15 days, body temperature is down to normally, and cough alleviates, and hemogram is normal, and symptom disappears substantially, and Chest X-rays two lung is normal.Follow up a case by regular visits to and do not recur.
In certain, man, 64 years old.Asthma is sent out repeatedly, invades outside wind and cold, cough aggravation, dyspnea with rapid and short breath; Floating and tense pulse.Treat with this side of the present invention; Take medicine, after 10 days, Etoscol, expectoration reduces, and after controlling 2 weeks altogether, all diseases disappear, and follow up a case by regular visits to and have no recurrence in 2 years.
Liu, female, 40 years old, whenever winter-spring season outbreak, to exhale during outbreak particularly difficulty, can not put down sleeping, two shoulder towering-ups, the wing of nose and shoulder neck, stomach wall flesh are all movable with breathing, whistling sound in the throat, auscultation two lung has extensive wheezing sound and dry rale, and percussion is hyperresonant note, and inferior boundary of lung reduces.X-ray rabat shows two increased bronchovascular shadows, blood routine examination, and numeration of leukocyte and eosinophilic granulocyte slightly increase.Treat 4 courses for the treatment of with this side of the present invention, follow up a case by regular visits to 1 year, asthma is not sent out.
Claims (2)
1. treat a bronchitic Flos Farfarae composition of medicine, it is characterized in that: by weight, by Flos Farfarae 40-50 gram, Cortex Mori 40-50 gram, Radix Platycodonis 40-50 gram, Radix Stemonae 40-50 gram, Radix Glycyrrhizae 40-50 gram, Periostracum Cicadae 6-25 gram, Bombyx Batryticatus 10-25 gram; Pulverize, packaging, obtains product.
2. treat a bronchitic Flos Farfarae composition of medicine, it is characterized in that: by weight, by Flos Farfarae 40-50 gram, Cortex Mori 40-50 gram, Radix Platycodonis 40-50 gram, Radix Stemonae 40-50 gram, Radix Glycyrrhizae 40-50 gram, Periostracum Cicadae 6-25 gram, Bombyx Batryticatus 10-25 gram; Adopt the method for prior art, make Tablet and Capsula product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510865957.7A CN105362865A (en) | 2015-11-29 | 2015-11-29 | Tussilago farfara combination medicine for treating bronchitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510865957.7A CN105362865A (en) | 2015-11-29 | 2015-11-29 | Tussilago farfara combination medicine for treating bronchitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105362865A true CN105362865A (en) | 2016-03-02 |
Family
ID=55365816
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510865957.7A Pending CN105362865A (en) | 2015-11-29 | 2015-11-29 | Tussilago farfara combination medicine for treating bronchitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105362865A (en) |
-
2015
- 2015-11-29 CN CN201510865957.7A patent/CN105362865A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100563693C (en) | A kind of Chinese medicine composition of orally taken for curing chronic bronchitis | |
| CN103599352B (en) | The medicine for the treatment of acute pharyngolaryngitis | |
| CN102716374A (en) | Pill for treating bronchitis | |
| CN102716351A (en) | Traditional Chinese medicine electuary for clearing heat and reducing fever | |
| CN105343720A (en) | Cortex lycii radicis composition medicine for treating bronchitis | |
| CN102028374A (en) | Medicinal pillow for treating insomnia | |
| CN105362865A (en) | Tussilago farfara combination medicine for treating bronchitis | |
| CN105362545A (en) | Pediatric bronchial asthma treatment pharmaceutical composition containing herba houttuyniae | |
| CN105878990A (en) | Traditional Chinese medicine for curing allergic asthma | |
| CN105327055A (en) | Cudweed combined medicine for treating chronic bronchial asthma | |
| CN105327196A (en) | Traditional Chinese medicine composition for treating chronic pneumonia | |
| CN102688400B (en) | Succus bambusae traditional Chinese medicine oral liquid for treating cough and preparation method for oral liquid | |
| CN106267081A (en) | Oletum Trogopterori composition of medicine | |
| CN105412534A (en) | White mulberry root bark combined medicine for treating bronchitis | |
| CN105327321A (en) | Periostracum cicada combinational medicine for treating asthma in elderly | |
| CN105362866A (en) | Gynostemma pentaphyllum combination medicine for treating asthma | |
| CN105412866A (en) | Cassia twig combined medicine for treating asthma in elderly | |
| CN106177872A (en) | Radix Rehmanniae Preparata composition of medicine | |
| CN105327101A (en) | Prepared rehmannia root combined medicine for treating chronic bronchitis | |
| CN103566148A (en) | Traditional Chinese medicine for enhancing immunity | |
| CN103549271A (en) | Health-protection traditional Chinese medicinal porridge capable of improving insomnia | |
| CN106177869A (en) | Herba Asari composition of medicine | |
| CN106310181A (en) | Radix rehmanniae composition drug | |
| CN105395746A (en) | Medicine for treating asthma in elderly | |
| CN106215162A (en) | A kind of Herba Andrographis composition of medicine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160302 |
|
| WD01 | Invention patent application deemed withdrawn after publication |